Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System

Ophthalmic Surg Lasers Imaging Retina. 2018 Dec 1;49(12):913-917. doi: 10.3928/23258160-20181203-01.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Delayed-Action Preparations
  • Drug Delivery Systems*
  • Humans
  • Intravitreal Injections / instrumentation
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Wet Macular Degeneration / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Delayed-Action Preparations
  • Vascular Endothelial Growth Factor A
  • brolucizumab